Board meeting on Oct 29, 2026 to consider Q2 FY26 results

Results View source PDF Explain this filing

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹357.00

prior close

₹358.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-0.2% vs market

Pharmaceuticals peers, median of 173sector+0.0%+0.5% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.7

15m

+0.6

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+0.7-0.2+0.0+0.5

Next day

-2.0-1.0-1.0-1.2-0.8

-4.1-3.6-0.5-2.8-1.2

-3.4-4.5+1.2-3.9+0.5

-8.1-6.8-1.4-5.0-3.1

-5.1-6.4+1.3-3.9-1.2

+5.6pendingpending-0.9+6.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ind-Swift Laboratories has informed BSE and NSE that its Board of Directors will meet on Thursday, October 29, 2026, to consider, approve and take on record the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026. The trading window for dealing in company securities is already closed, as communicated earlier on September 28, 2026.

Likely market impact

Routine advance intimation. No impact on stock yet; investors should watch the results announcement on or after Oct 29 for earnings details.